Kinnate Biopharma Inc

NASDAQ:KNTE   3:59:23 PM EDT
22.58
+0.39 (+1.76%)
Earnings Announcements

Kinnate Biopharma Inc Reports Full Year 2020 Financial Results

Published: 03/29/2021 21:11 GMT
Kinnate Biopharma Inc (KNTE) - Kinnate Biopharma Inc. Reports Full Year 2020 Financial Results.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.